cis-piperidine-3,4-diol hydrochloride | 443648-89-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: cis-piperidine-3,4-diol hydrochloride
• 英文别名: (3R,4S)-piperidine-3,4-diol Hydrochloride；(3R,4S)-piperidine-3,4-diol;hydrochloride
• CAS: 443648-89-3
• 化学式: C₅H₁₁NO₂*ClH
• mdl: MFCD27918518
• 分子量: 153.609
• InChiKey: DGTFLCBNCAMFON-UYXJWNHNSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.57
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  52.5
• 氢给体数：
  4
• 氢受体数：
  3

安全信息

• 储存条件：
  室温

反应信息

• 作为反应物：
  描述：

  4-香豆酸 、 cis-piperidine-3,4-diol hydrochloride 在 N,N-二异丙基乙胺 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 16.0h， 以68%的产率得到(E)-1-(cis-3,4-dihydroxypiperidin-1-yl)-3-(4-hydroxyphenyl)prop-2-en-1-one
  参考文献：
  名称：

  Synthesis, molecular modeling and evaluation of α-glucosidase inhibition activity of 3,4-dihydroxy piperidines

  摘要：

  Biological evaluation of 3,4-dihydroxy piperidines as alpha-glucosidase inhibitors is being reported for the first time. Forty-five derivatives (amides, di-amides and sulfonamides) were made using cis and trans 3,4-dihydroxy piperidines to evaluate their alpha-glucosidase inhibition activity. Polar groups (-OH, -NH2) on phenyl ring having derivatives 5i, 5l, 7g, 7i & 12j showed excellent activity compared to standard references. Acarbose, Voglibose and Miglitol were used as standard references. Molecular docking simulations were done for compounds to identify important binding modes responsible for inhibition activity of alpha-glucosidase. (C) 2018 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2018.02.072
• 作为产物：
  描述：

  1,2,3,6-四氢吡啶 在 盐酸 、 potassium osmate(VI) dihydrate 、 sodium carbonate 、 N-甲基吗啉氧化物 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 二氯甲烷 、 水 为溶剂， 反应 26.0h， 生成 cis-piperidine-3,4-diol hydrochloride
  参考文献：
  名称：

  Synthesis, molecular modeling and evaluation of α-glucosidase inhibition activity of 3,4-dihydroxy piperidines

  摘要：

  Biological evaluation of 3,4-dihydroxy piperidines as alpha-glucosidase inhibitors is being reported for the first time. Forty-five derivatives (amides, di-amides and sulfonamides) were made using cis and trans 3,4-dihydroxy piperidines to evaluate their alpha-glucosidase inhibition activity. Polar groups (-OH, -NH2) on phenyl ring having derivatives 5i, 5l, 7g, 7i & 12j showed excellent activity compared to standard references. Acarbose, Voglibose and Miglitol were used as standard references. Molecular docking simulations were done for compounds to identify important binding modes responsible for inhibition activity of alpha-glucosidase. (C) 2018 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2018.02.072

文献信息

• [EN] INHIBITORS OF MUTANT FORMS OF EGFR<br/>[FR] INHIBITEURS DE FORMES MUTANTES DE L'EGFR
  申请人：BLUEPRINT MEDICINES CORP

  公开号：WO2021133809A1

  公开（公告）日：2021-07-01

  The present disclosure provides a compound represented by structural formula (I) : or a pharmaceutically acceptable salt thereof useful for treating a cancer.

  本公开提供了一种由结构公式（I）表示的化合物：或其药用可接受的盐，用于治疗癌症。
• [EN] 1 -OXO-1,2-DIHYDROISOQUINOLIN-7-YL-(5-SUBSTITUTED-THIOPHEN-2-YL)-SULFONAMIDE COMPOUNDS, FORMULATIONS CONTAINING THOSE COMPOUNDS, AND THEIR USE AS AICARFT INHIBITORS IN THE TREATMENT OF CANCERS<br/>[FR] COMPOSÉS 1-OXO-1,2-DIHYDROISOQUINOLÉINE-7-YL-(5-SUBSTITUÉ-THIOPHÉN-2-YL)-SULFONAMIDE, FORMULATIONS CONTENANT CES COMPOSÉS ET LEUR UTILISATION COMME INHIBITEURS D'AICARFT DANS LE TRAITEMENT DE CANCERS
  申请人：LILLY CO ELI

  公开号：WO2016089670A1

  公开（公告）日：2016-06-09

  1-Oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as AICARFT inhibitors.

  1-Oxo-1,2-二氢异喹啉-7-基-(5-取代噻吩-2-基)-磺酰胺化合物，含有这些化合物的配方，以及它们作为AICARFT抑制剂的用途。
• Stereoelectronic Substituent Effects in Polyhydroxylated Piperidines and Hexahydropyridazines
  作者：Henrik Helligsø Jensen、Laila Lyngbye、Astrid Jensen、Mikael Bols

  DOI：10.1002/1521-3765(20020301)8:5<1218::aid-chem1218>3.0.co;2-x

  日期：2002.3.1

  group in the 4-position relative to the amine were 0.4 pH units more acidic than the corresponding compound with an axial OH. A similar effect was observed for the COOMe substituent. The difference in electron-withdrawing power of axial and equatorial substituents was explained by a difference in charge-dipole interactions in the two systems. Since this stereoelectronic substituent effect causes differences

  从大量的羟基化哌啶和六氢哒嗪的共轭酸的pK（a）值，发现在具有轴向或赤道羟基（OH）基团（相对于胺而言）的立体异构体之间，碱度存在一致的差异。与其他相同的具有轴向OH基团的化合物相比，在3位具有赤道OH基团的化合物的酸度高0.8个pH单位，而相对于胺在4位具有赤道OH基团的化合物的酸度比其他的酸碱度高0.4个pH单位。带有轴向OH的相应化合物。对于COOMe取代基观察到类似的效果。轴向和赤道取代基的吸电子能力的差异是由两个系统中电荷-偶极相互作用的差异解释的。由于这种立体电子取代基效应导致不同构象异构体的碱性不同，因此发现某些哌啶和六氢哒嗪在质子化时会改变构象。描述了一种预测立体异构体的哌啶的pK（a）的方法。
• CYCLIC THIENOURACIL-CARBOXAMIDES AND USE THEREOF
  申请人：BAYER PHARMA AKTIENGESELLSCHAFT

  公开号：US20160244461A1

  公开（公告）日：2016-08-25

  The present application relates to novel 2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidine-6-carboxamide derivatives (“thienouracil”-carboxamides), to processes for their preparation, to their use alone or in combinations for the treatment and/or prevention of diseases and to their use for the preparation of medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of pulmonary and cardiovascular disorders.

  本申请涉及新型2,4-二氧-1,2,3,4-四氢噻吩[2,3-d]嘧啶-6-羧酰胺衍生物（“噻吩尿嘧啶”-羧酰胺），其制备方法，它们单独或组合用于治疗和/或预防疾病以及它们用于制备治疗和/或预防疾病的药物，特别是用于治疗和/或预防肺部和心血管疾病。
• Preparation of iminosugars from aminopolyols <i>via</i> selective oxidation using galactose oxidase
  作者：Kathryn Yeow、Marianne B. Haarr、Jimmy Muldoon、Elaine O'Reilly

  DOI：10.1039/d2cc04989a

  日期：——

  Selective oxidation of minimally protected aminopolyols, using galactose oxidase variant F₂, affords biologically relevant iminosugars.

  使用半乳糖氧化酶F2变种，选择性氧化最小保护氨基多醇，可以得到具有生物学意义的亚胺糖。